News Quantified

NVS – novartis ag (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Novartis Secures Positive EU Backing for SMA Gene Therapy Itvisma [Yahoo! Finance]

Novartis receives positive CHMP opinion for Itvisma® for spinal muscular atrophy (SMA) [Yahoo! Finance]

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants [Yahoo! Finance]

Novartis malaria treatment Coartem® Baby receives WHO prequalification, paving way for greater access for newborns and young infants

Novartis: Buy Thesis Fades Into Q1 2026 Results (Rating Downgrade) [Seeking Alpha]

1.6%

BEAT

-1.7%

MISS

-0.1%

BEAT

-0.3%

BEAT

Sanford C. Bernstein

Form 6-K NOVARTIS AG For: Mar 18

Form FWP NOVARTIS AG Filed by: NOVARTIS AG

Form 144 NOVARTIS AG Filed by: Marshall Fiona

Form 144 NOVARTIS AG Filed by: Bulto Carulla Victor

Form S-8 NOVARTIS AG

Top News Gainers

3/4 BRIEF-Novartis has stock to cover production, distribution for now, monitoring India API changes [Reuters] 4.8%

7/17 The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On [The Motley Fool] 4.5%

5/23 Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency 3.6%

8/11 5 Reasons Novartis Shareholders Aren't Shaken [The Motley Fool] 3.4%

8/7 Glancy Prongay & Murray LLP Announces Investigation on Behalf of Novartis AG Investors (NVS) 2.7%

4/4 Novartis AG (NYSE: NVS) had its "buy" rating re-affirmed by analysts at Goldman Sachs Group Inc. They now have a $116.00 price target on the stock. 2.7%

4/13 Novartis: Recent Selloff Has Presented A Buying Opportunity [Seeking Alpha] 2.4%

3/24 BRIEF-Novartis says Zolgensma helped SMA patients up to 5 years after dosing [Reuters] 2.2%

4/2 New York City hospital worker who caught coronavirus returns to treat patients [FOX News] 2.2%

3/10 INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Novartis AG and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 1.9%

Top News Decliners

2/24 BRIEF-Novartis Announces FDA And EMA Filing Acceptance Of Ofatumumab [Reuters] -6.9%

4/28 Novartis sales, profits rise in first quarter on COVID-19 buying rush [Reuters (UK)] -3.2%

2/25 Novartis AG (NYSE: NVS) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating. -3.0%

9/13 BRIEF-Novartis Says Neuronal And Glial Filaments Have Potential To Support Management Of MS Patient [Reuters] -2.8%

4/6 Special Report: Doctors embrace drug touted by Trump for COVID-19, without hard evidence it works [Reuters] -2.7%

3/3 BRIEF-Novartis Receives Health Canada Approval For Mayzent [Reuters] -2.7%

3/20 UPDATE 2-Novartis to donate malaria drug in fight against coronavirus [Reuters] -2.4%

7/11 BRIEF-Novartis, Amgen And Banner Alzheimer's Institute Discontinue Clinical Program With Bace Inhibitor CNP520 [Reuters] -2.3%

3/9 ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against Novartis AG – NVS -2.2%

3/20 Novartis to donate malaria drug in fight against coronavirus [Reuters] -2.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day